Tom Schrader
Analyst, PTIG
Replay available
Novavax, Inc. (NASDAQ: NVAX) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.

Analyst, PTIG
Analyst, Bank of America
Analyst, Citi
Analyst, Jefferies
Analyst, B. Riley Securities
Vice President, Investor Relations
President and Chief Executive Officer
Chief Financial Officer and Treasurer
Watch the replay and follow the connected company analysis, news, and investor updates for Novavax, Inc..
WEBVTT 00:00:00.000 -- 00:00:05.220 Good morning and welcome to Novavac's second quarter 2025 Financial Results 00:00:05.220 -- 00:00:07.980 and Operational Highlights conference call. 00:00:07.980 -- 00:00:10.600 All participants will be in a listen-only mode. 00:00:10.600 -- 00:00:14.720 Should you need assistance, please signal a conference specialist by pressing the star 00:00:14.720 -- 00:00:16.960 key followed by zero. 00:00:16.960 -- 00:00:21.060 After today's presentation, there will be an opportunity to ask questions. 00:00:21.060 -- 00:00:25.580 To ask a question, you may press star then one on your touchtone phone. 00:00:25.580 -- 00:00:29.560 To withdraw your question, please press star one again. 00:00:29.560 -- 00:00:32.620 Please note this event is being recorded. 00:00:32.620 -- 00:00:36.500 I would now like to turn the conference over to Louis Sinet, Vice President of Vestor 00:00:36.500 -- 00:00:40.040 Relations. Please go ahead. 00:00:41.120 -- 00:00:46.200 Good morning and thank you all for joining us today to discuss our second quarter 2025 00:00:46.200 -- 00:00:49.260 Financial Results and Operational Highlights. 00:00:49.260 -- 00:00:54.320 A press release announcing our results is available on our website at Novavax.com 00:00:54.320 -- 00:01:00.240 and an audio archive of this conference call will be available on our website later today. 00:01:00.240 -- 00:01:05.120 Please turn to slide two. Before we begin with prepared remarks, I need to remind you 00:01:05.120 -- 00:01:09.580 that this presentation includes forward-looking statements, including but not limited 00:01:09.580 -- 00:01:14.900 to statements related to Novavac's corporate strategy and operating plans, 00:01:14.900 -- 00:01:20.300 its strategic priorities, its partnerships and exp...